spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Frazier Healthcare 

 HSMN NewsFeed - 29 Nov 2021
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 Jun 2020
Proprio Raises $23 Million in Series A Funding Led by DCVC
Devices Surgery Venture Capital
 HSMN NewsFeed - 1 Apr 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 16 Jan 2020
Frazier Healthcare Partners Announces Multiple Promotions on its Life Sciences Team
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 15 Jul 2019
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2019
Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2017
Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Nov 2017
Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Sep 2017
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Jul 2017
CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 May 2017
Iterum Secures $65 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Mar 2017
SutroVax Announces Closing of $64M via Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 10 May 2016
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 30 Mar 2016
Zavante Therapeutics Closes $45 Million Series A Financing In Support Of U.S. Development For A First-In-Class Injectable Antibiotic
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Mar 2016
Leading BioSciences Expands Executive Leadership Team, Appoints Dr. Howard Dittrich as Chief Medical Advisor and Stephen Keane as Senior Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2015
Allena Pharmaceuticals Raises $53 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jul 2015
AnaptysBio Secures $40 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2015
Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2014
Cidara Therapeutics Completes $32 Million Series A Financing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2013
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
Devices Orthopaedic
 HSMN NewsFeed - 19 Dec 2012
Industry Veteran Hank Struik Appointed As LABSCO's Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2012
Moximed's Implantable Knee Spring Successfully Reduces Pain and Quickly Returns Normal Function to Osteoarthritis Patients
Devices Orthopaedic
 HSMN NewsFeed - 3 Aug 2012
Atterocor Launches Innovative Company Focused on Accelerated Development of Treatment for Adrenal Cancer; Secures $16 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 May 2012
Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2011
Allena Pharmaceuticals Launches with $15 Million Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Sep 2011
Oceana Therapeutics Announces U.S. Launch of Solesta(R), The Only Nonsurgical FDA Approved Treatment for Patients Who Fail Conservative Therapy for Fecal (Bowel) Incontinence
Devices
 HSMN NewsFeed - 31 May 2011
FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence
Devices Gastroenterology FDA
 HSMN NewsFeed - 12 Apr 2011
Portola Pharmaceuticals Appoints Dr. James Topper to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2011
Oceana Therapeutics Gets FDA Approvable Letter for Solesta(R), a Significant Treatment Option for Fecal (Bowel) Incontinence; the Only Minimally Invasive Therapy for More Severe Bowel Control Problems
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Dec 2010
Oceana Therapeutics Announces FDA Advisory Committee Recommends Approval of Solesta(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Sep 2010
Tobira Therapeutics Inc. Raises $31 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2010
BARRX Medical, Inc. Completes $15 Million Growth Financing
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 2 Jul 2010
Lilly to Acquire Alnara Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jun 2010
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 May 2010
Nuon Therapeutics Names Lee Rauch Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Feb 2010
Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2010
Alnara Pharmaceuticals Secures $35 Million in Series B Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jan 2010
VentiRx Pharmaceuticals Raises $25 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 3 Nov 2009
Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2009
Calypso Medical Closes $50 Million Venture Financing Round
Devices Oncology Venture Capital
 HSMN NewsFeed - 16 Jul 2009
Nuon Therapeutics Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2009
Clovis Oncology Raises $145 Million in Start-Up Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 May 2009
Calistoga Pharmaceuticals Raises $30 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Apr 2009
Endologix Appoints Vice President of Global Marketing
Devices Interventional Personnel
 HSMN NewsFeed - 30 Oct 2008
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Oct 2008
Intradigm Raises $18.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Aug 2008
Stromedix Receives Orphan Drug Designation for STX-100 in Chronic Allograft Nephropathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jul 2008
CVRx(R), Inc. Closes $84 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 28 Jul 2008
EBR Systems, Inc. Raises $35M Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 15 Jul 2008
Collegium Pharmaceutical Announces Completion of Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jun 2008
Three Industry Veterans Join Ascension Orthopedics
Devices Orthopaedic Personnel
 HSMN NewsFeed - 28 Apr 2008
Nuon Therapeutics Inc. Completes $27 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Feb 2008
Calistoga Pharmaceuticals Announces Appointment of R. Lee Douglas, 22-Year Biotechnology/Pharmaceutical Industry Veteran, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2008
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
Devices Orthopaedic Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2008
Calistoga Pharmaceuticals Announces Completion of Its Series A Financing -- Investors Increased Funding by 25% to Total $26.2 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 7 Nov 2007
Medicare Sets Physician Payment Rate for Percutaneous Kidney Cryoablation
Devices Oncology Reimbursement
 HSMN NewsFeed - 5 Nov 2007
Medicare Increases 2008 Hospital Reimbursement Rates for Cryoablation Treatments of Prostate Cancer
Devices Oncology Reimbursement
 HSMN NewsFeed - 9 Oct 2007
Metastatix Closes $35 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2007
FlowCardia, Inc. Raises $30 Million in Series C Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Biopharmaceuticals HIV/AIDS Venture Capital Personnel
 HSMN NewsFeed - 20 Jul 2007
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 May 2007
Arete Therapeutics Raises $35 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 May 2007
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
Devices Personnel
 HSMN NewsFeed - 15 May 2007
Marcadia Biotech Completes $15 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 May 2007
Pegasus Biologics Closes $20 Million Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 7 May 2007
Portola Pharmaceuticals, Inc. Announces Completion of $70 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Apr 2007
Xoft, Inc., Announces Additional Funding for Breakthrough Electronic Brachytherapy Technology
Devices Oncology Venture Capital
 HSMN NewsFeed - 12 Mar 2007
ZONARE Medical Systems Announces Additional Funding for Revolutionary Zone Sonography(TM) Technology
Devices Venture Capital
 HSMN NewsFeed - 6 Mar 2007
VentiRx Pharmaceuticals Announces $28.9 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2007
Calistoga Pharmaceuticals, A Newly Formed Drug Development Company, Announces Its Formation and Completion of a $21 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2006
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 14 Sep 2006
Amicus Therapeutics Raises $60 Million Series D Financing; Company Also Makes Two Key Executive Appointments
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Jul 2006
BARRX Medical, Inc. Secures $27.8 Million Series C Venture Funding
Devices Venture Capital
 HSMN NewsFeed - 26 Jun 2006
Interventional Rhythm Management Changes Name to InnerPulse and Announces a Move to a New Expanded Office, Lab, Manufacturing Facility
Devices Cardiology
Return to NewsFeed  

 Additional items found! 17

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 17 additional stories matching:
Frazier Healthcare
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!